ARCHIVES

NCI’s $65 Million to NTP Will Be Controversial, Untouchable; Spectre Of Another Backlog Looms

This article is from The Cancer Letter archive.

Vol. 06 No. 06 | February 8, 1980

Download PDF Visit The Full Archive

Related Articles

In Congress: Senate, House Reports List Priorities For NCI

August 8, 1997

New Phase III Follow-Up Data of Yervoy Trial Shows 19 Percent Survival at Four Years

October 26, 2012

Senate Committee Proposes $100 Million DOD Prostate Cancer Research Program

July 12, 1996

STI-571 Effects Are Lasting Against GI Stromal Tumors

July 26, 2002

NCI Funds Proteomic Technology Assessment Grants.

September 29, 2006

Cancer Center Lineup complete: 11 Renewals, Funding Continued for Three, Two Unfunded

September 28, 1990